Lyme Disease Treatment Insurance Claim Denied? How to Appeal

Lyme disease is the most common vector-borne illness in the United States, with over 500,000 new diagnoses estimated annually. Caused by Borrelia burgdorferi and transmitted through infected blacklegged ticks, Lyme disease can cause serious multi-system illness affecting the joints, heart, and nervous system. Lyme disease treatment denials are among the most contested in American healthcare — fueled by genuine clinical controversy, conflicting guidelines, and insurer cost-containment strategies. This guide explains the denial landscape, your legal rights, and how to build a winning appeal.

Why Insurers Deny Lyme Disease Treatment

Treatment duration limits are the most common source of denial. Insurers follow IDSA 2006 guidelines recommending 2 to 4 weeks of antibiotics for standard presentations. Extended courses are denied as unsupported — directly conflicting with treating physicians following ILADS guidelines for patients with persistent symptoms.

PTLDS treated as non-medical: After standard treatment, some patients experience ongoing fatigue, cognitive difficulties, and musculoskeletal pain. Insurers do not support extended antibiotics for post-treatment Lyme disease syndrome (PTLDS) and frequently characterize continued treatment as not medically necessary.

IV antibiotic therapy denied: IV ceftriaxone — the standard of care for neurologic Lyme, cardiac Lyme, and Lyme arthritis not responding to oral antibiotics — is frequently denied, often through incorrect reclassification of the clinical presentation or claim that oral alternatives suffice.

Diagnostic testing disputes: FDA-approved modified two-tier testing and specialty diagnostic approaches used by Lyme-treating physicians are denied as experimental or unproven, blocking proper diagnosis.

Specialist and out-of-network care: Infectious disease physicians, neurologists, and cardiologists managing Lyme complications may be denied as out-of-network, and specialized Lyme disease centers may have their claims denied as involving experimental treatment.

How to Appeal

Step 1: Read the denial and identify the specific basis

Request the full claim file and the clinical criteria used to deny your claim. The denial basis — treatment duration, medical necessity, experimental designation, or diagnostic testing — determines your appeal strategy. Do not argue every point at once; focus on the exact reason stated.

Step 2: Gather objective clinical documentation

Obtain your Lyme disease test results, documentation of initial presentation (erythema migrans rash, fever, joint symptoms, cardiac or neurological involvement), and records of all treatments tried. For late-stage or persistent presentations, compile objective findings: inflammatory markers, nerve conduction studies, joint fluid analysis, and brain MRI. Objective abnormalities are far harder for insurers to deny than subjective symptom reports.

Step 3: Use IDSA guidelines strategically

For standard Lyme, early disseminated disease, neurologic Lyme, cardiac Lyme, and Lyme arthritis — IDSA guidelines themselves support the treatment. If your insurer is denying care that IDSA's own guidelines recommend (such as IV ceftriaxone for Lyme neuroborreliosis), cite the IDSA guidelines directly in your appeal letter. Do not concede this ground.

Step 4: Invoke state Lyme disease laws

Several states — particularly in the Northeast where Lyme is endemic — have enacted specific protections. Rhode Island, Massachusetts, and New Hampshire require insurers to cover long-term antibiotic treatment when prescribed by a licensed physician, regardless of treatment duration. Connecticut's Lyme Disease Treatment Act protects treating physicians and contains coverage provisions. New York and New Jersey have varying protections. If you are in one of these states, cite the specific statute and demand the insurer explain why it is not complying.

Step 5: Submit a formal internal appeal with supporting documentation

File a written appeal within 180 days of the denial. Your appeal should include your treating physician's detailed letter, clinical records, applicable guidelines, and state law citations. Send by certified mail and through the insurer's portal. Keep copies and delivery confirmation of everything.

Step 6: Escalate to External Independent Review: Complete Guide" class="auto-link">external review and state regulators

If the internal appeal fails, request independent external review immediately. File a complaint with your state insurance commissioner — especially if a state Lyme law applies. Organizations like LymeDisease.org and the Bay Area Lyme Foundation maintain patient advocacy resources that may assist with appeals.

What to Include in Your Appeal

• Two-tier serology results (ELISA and Western blot) with physician interpretation and clinical correlation
• Documentation of tick exposure history and initial presentation with dates
• Objective clinical findings: joint fluid analysis, neuropsychological testing, cardiac monitoring, or imaging results
• Treating physician's letter citing specific IDSA or ILADS guidelines applicable to your diagnosis category
• State Lyme disease statute citation with analysis of how your denial may violate state law

Fight Back With ClaimBack

Lyme disease treatment denials involve genuine clinical and legal complexity, but insurers do not always get the last word. ClaimBack structures your appeal around your specific clinical facts, applicable guidelines, and state law to give you the strongest possible foundation. ClaimBack generates a professional appeal letter in 3 minutes. Start your free claim analysis → Free analysis · No credit card required · Takes 3 minutes

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal